An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

✍ Scribed by Zhou, Z.; Sehn, L. H.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Crosby-Thompson, A.; Vanderplas, A.; Zelenetz, A. D.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; Kaminski, M. S.; Czuczman, M. S.; Millenson, M.; Niland, J.; Gascoyne, R. D.; Connors, J. M.; Friedberg, J. W.; Winter, J. N.

• Book ID: 125458749
• Publisher: American Society of Hematology
• Year: 2014
• Tongue: English
• Weight: 528 KB
• Volume: 123
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2013-09-524108